{"timestamp": 1771600222.3192673, "value": {"ticker": "LIMN", "company_name": "Liminatus Pharma, Inc.", "short_name": "Liminatus Pharma, Inc.", "sector": "Healthcare", "industry": "Biotechnology", "country": "United States", "market_cap": 6865283, "float_shares": 5555287, "shares_outstanding": 31064633, "short_ratio": 0.48, "short_percent_of_float": 0, "shares_short": 60060, "shares_short_prior": 115893, "insider_percent_held": 0.43912, "institution_percent_held": 0.00806, "total_cash": 724502, "total_debt": 1442500, "total_revenue": 0, "revenue_growth": 0, "earnings_growth": 0, "profit_margins": 0.0, "gross_margins": 0.0, "operating_margins": 0.0, "debt_to_equity": 0, "current_ratio": 0.42, "book_value": -0.061, "price_to_book": -3.6229508, "operating_cashflow": -9717065, "free_cashflow": -676760, "price": 0.221, "52w_high": 33.66, "52w_low": 0.2116, "avg_volume": 7422603, "avg_volume_10d": 43597110, "full_time_employees": 0, "audit_risk": 0, "overall_risk": 0}}